Web Analytics

3 Latest Announced Rounds

  • $15,000,000
    Seed

    4 Investors

    Technology, Information and Internet
    Oct 2nd, 2025
  • $4,693,900
    Pre-Seed

    1 Investors

    Software Development
    Oct 2nd, 2025
  • $4,000,000
    Seed

    1 Investors

    Software Development
    Oct 2nd, 2025
$1,204.19M Raised in 63 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Athernal Bio

start up
United Kingdom - Cambridge
  • 02/10/2025
  • Unknown
  • $4,718,630

Developing targeted immunotherapies to treat high-risk clonal haematopoiesis (CH)—the precursor to blood cancers—so we can stop cancer before it starts.


Related People

Colin FreundFounder

Colin Freund United States - New York City Metropolitan Area

C-level executive with experience in both private and public biotechnology companies, with 18 years' experience leading multinational teams that drive revenue generation and corporate value creation: company leadership (including venture fundraising); strategic planning, business/corporate development and M&A ($500M+ in multiple licensing/M&A transactions); corporate restructuring; alliance management; commercial development and product launch preparation; supply chain optimization; organizational development; investor relations/fundraising; and business interface on regulatory strategy in the USA, Europe and Asia.